Legal
Filter News
Found 9,342 articles
-
Days after Purdue Pharma reached a combined $8.4 billion criminal and civil settlement with the U.S. Department of Justice, the OxyContin drugmaker pleaded guilty to three criminal charges to resolve its role in the ongoing opioid crisis in the United States.
-
Guardant Health is taking Roche-owned Foundation Medicine to court over a patent dispute for their liquid biopsy technology, further heating up the rivalry between the two cancer detection companies.
-
Two months after he was stepped down from the role of chief executive officer of Legend Biotech, Fangliang “Frank” Zhang has been arrested for smuggling genetic resources from the People’s Republic of China.
-
Parker H. “Pete” Petit, the former chief executive officer of wound care company MiMedx was convicted of fraud and making false statements to the U.S. Securities and Exchange Commission, following a months-long investigation into the company’s financial records. William Taylor, the company’s form...
-
Bicycle Therapeutics Announces Settlement of Patent Dispute with Pepscan Systems B.V.
11/20/2020
Bicycle Therapeutics plc (NASDAQ:BCYC), a clinical-stage biotechnology company pioneering a new and differentiated class of therapeutics based on its proprietary bicyclic peptide (Bicycle®) technology, today announced that it has entered into a settlement and license agreement with Pepscan Systems B.V. regarding Bicycle’s use of Pepscan’s CLIPS peptide technology.
-
A settlement valued at $8.34 billion was reached between Purdue Pharma and the Justice Department on Tuesday, which required the drug company to plead guilty to three felonies related to its marketing and distribution of OxyContin.
-
Sanofi was formally charged over Depakine, its epilepsy drug, for not taking action when they first discovered the fetal risks when taken by pregnant women.
-
Abbott Sues Former VP Over Trade Secrets, Similar Cases Expected to Follow in “New Normal”
11/5/2020
Abbott is suing their former VP Jerome Clavel over allegations of trade secret theft with intent to share with his new employer, rival diagnostics company Bio-Rad. -
Both sides claim to be pleased with arbitration results in dispute over Prevail CEO's alleged breach of contract from time with Allector.
-
Halberd Corp. Retains Prestigious Patent Law Firm on Covid-19-Related and Other Disease Technologies
10/27/2020
Halberd Corporation (OTC PINK: HALB ) has retained the services of a prestigious Pittsburgh, PA law firm, Ference & Associates , to handle its intellectual property matters. The initial application focuses on patenting Halberds base Covid-19 antibody as well as an entire new class of antibody conjugate.
-
Shaun Thaxter, the former chief executive officer of Indivior, was sentenced in federal court Thursday, four months after pleading guilty to one misdemeanor count of sharing false information about the addictive properties of Suboxone Film, an opioid-based product.
-
The settlement stems from multi-year criminal and civil investigations into Purdue’s marketing practices related to its powerful prescription painkiller, OxyContin, which critics have argued facilitated the opioid epidemic.
-
Purdue Pharma Reaches Agreement With U.S. Department of Justice
10/21/2020
- Agreement resolves DOJ investigations into past marketing practices - Settlement funds primarily directed to state, local and tribal governments for opioid crisis abatement purposes - Agreement brings Purdue closer to its ultimate goal of delivering more than $10 billion in value to address the opioid crisis
-
SHAREHOLDER ALERT: Monteverde & Associates PC Announces an Investigation of BioSpecifics Technologies Corp. - BSTC
10/21/2020
Juan Monteverde , founder and managing partner at Monteverde & Associates PC , a national securities firm headquartered at the Empire State Building in New York City , is investigating BioSpecifics Technologies Corp. ("BioSpecifics" or the "Company") ( BSTC ) relating to its proposed acquisition by Endo International PLC. Unde
-
Align Technology Backs out of Patent Infringement Cases Against 3Shape
10/21/2020
On October 19, 2020, apparently recognizing that its litigation strategy against 3Shape in Delaware was not working, Align Technology asked that the entire District Court case DC 1649 be dismissed, along with a patent from the DC 1950 case, thereby giving up its previous assertion of a total of 8 patents against 3Shape in the Delaware litigations. “While we are pleased that Align has backed out of a patent infring
-
Catalyst Pharmaceuticals has filed new patent infringement lawsuits against Jacobus Pharmaceuticals and PantherRX Rare LLC over a treatment for the rare autoimmune disease Lambert-Eaton Myasthenic Syndrome.
-
AntiCancer Files Second Lawsuit Against Certis Oncology
10/19/2020
AntiCancer, Inc., a worldwide leader in cancer research and the pioneer of patient-derived mouse models of cancer, announced today it has filed a second lawsuit against Certis Oncology Solutions, Inc. The companies are locked in a long-running legal dispute over hundreds of “immortalized” patient tumor samples which AntiCancer developed and alleges were stolen by Certis, a controversial startup which was originally founde
-
Catalyst Pharmaceuticals Announces Filing of Patent Infringement Actions Against Jacobus Pharmaceuticals and PantherRx
10/19/2020
Catalyst Pharmaceuticals, Inc. (Catalyst) (Nasdaq: CPRX), a commercial-stage biopharmaceutical company focused on developing and commercializing innovative therapies for people with rare debilitating, chronic neuromuscular and neurological diseases, today announced that it has filed a lawsuit in the U.S. District Court for New Jersey against Jacobus Pharmaceuticals, Inc. (Jacobus), and a lawsuit in the U.S. District Court for the Western Di
-
This week, the judge overseeing her trial denied all efforts from her legal team to dismiss more than a dozen criminal charges against the Theranos founder.
-
Mallinckrodt has filed for Chapter 11 bankruptcy amid growing lawsuits that allege the company has participated in fueling the opioid epidemic in the United States.